Feng Zhou

2.3k total citations
70 papers, 1.5k citations indexed

About

Feng Zhou is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Feng Zhou has authored 70 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 37 papers in Molecular Biology, 17 papers in Oncology and 10 papers in Cancer Research. Recurrent topics in Feng Zhou's work include Prenatal Substance Exposure Effects (6 papers), Liver physiology and pathology (5 papers) and Wnt/β-catenin signaling in development and cancer (5 papers). Feng Zhou is often cited by papers focused on Prenatal Substance Exposure Effects (6 papers), Liver physiology and pathology (5 papers) and Wnt/β-catenin signaling in development and cancer (5 papers). Feng Zhou collaborates with scholars based in China, United States and Chile. Feng Zhou's co-authors include Youssef Sari, Teresa A. Powrozek, Xiaoying Huang, James M. Gallo, Liying Wang, Xiliang Zha, Yong Yang, Yedy Israel, Zengxia Li and Dan Peng and has published in prestigious journals such as The Journal of Experimental Medicine, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

Feng Zhou

65 papers receiving 1.5k citations

Peers

Feng Zhou

ONCOL

PRM

PPCH

Francisco Dası́ Spain

Jung Sun Park South Korea

Weimin Sun United States

Shan Jiang China

Jianwei Ren China

Yuki Hattori Japan

Jeffrey D. Ritzenthaler United States

I‐Ling Lin Taiwan

Jung‐Hwa Oh South Korea

Francisco Dası́ Spain

Feng Zhou

1.0k ×1.2

287 ×1.1

199 ×0.8

ONCOL

162 ×1.0

PRM

49 ×0.4

PPCH

Citations per year, relative to Feng Zhou Feng Zhou (= 1×) peers Francisco Dası́

Countries citing papers authored by Feng Zhou

Since Specialization

Citations

This map shows the geographic impact of Feng Zhou's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Feng Zhou with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Feng Zhou more than expected).

Fields of papers citing papers by Feng Zhou

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Feng Zhou. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Feng Zhou. The network helps show where Feng Zhou may publish in the future.

Co-authorship network of co-authors of Feng Zhou

This figure shows the co-authorship network connecting the top 25 collaborators of Feng Zhou. A scholar is included among the top collaborators of Feng Zhou based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Feng Zhou. Feng Zhou is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Zhou, Feng, Guimei Yang, Yajing Liu, et al.. (2024). Abstract 7278: Discovery of a novel WRN inhibitor, ZM-3329 that efficiently inhibits MSI-H tumor growth. Cancer Research. 84(6_Supplement). 7278–7278. 1 indexed citations

Zhou, Feng, Guimei Yang, Yajing Liu, et al.. (2024). Abstract 661: An oral Cbl-b inhibitor with sustained T cell activation demonstrated robust anti-tumor efficacy along with enhanced infiltration and activation of functional T cells. Cancer Research. 84(6_Supplement). 661–661. 1 indexed citations

Kuang, Yi, Liting Xue, Tingting Li, et al.. (2024). SCR‐7952, a highly selective MAT2A inhibitor, demonstrates synergistic antitumor activities in combination with the S‐adenosylmethionine‐competitive or the methylthioadenosine‐cooperative protein arginine methyltransferase 5 inhibitors in methylthioadenosine phosphorylase‐deleted tumors. SHILAP Revista de lepidopterología. 5(10). e705–e705. 5 indexed citations

Zhou, Feng, Guimei Yang, Liting Xue, et al.. (2023). SCR-6852, an oral and highly brain-penetrating estrogen receptor degrader (SERD), effectively shrinks tumors both in intracranial and subcutaneous ER + breast cancer models. Breast Cancer Research. 25(1). 96–96. 8 indexed citations

Zhou, Feng, Luyao Li, Yanmao Wang, et al.. (2023). Pharmacological targeting of MTHFD2 suppresses NSCLC via the regulation of ILK signaling pathway. Biomedicine & Pharmacotherapy. 161. 114412–114412. 8 indexed citations

Pan, Lifeng, Feng Yang, Xianhua Cao, et al.. (2023). Identification of five hub immune genes and characterization of two immune subtypes of osteoarthritis. Frontiers in Endocrinology. 14. 1144258–1144258. 1 indexed citations

Wang, Fangfei, Jun Xie, Yang Liu, et al.. (2022). Identification of a glycolysis- and lactate-related gene signature for predicting prognosis, immune microenvironment, and drug candidates in colon adenocarcinoma. Frontiers in Cell and Developmental Biology. 10. 971992–971992. 13 indexed citations

Li, Xiaofang, Feng Zhou, Di Wu, et al.. (2020). Co-circulation of multiple reassortant H6 subtype avian influenza viruses in wild birds in eastern China, 2016–2017. Virology Journal. 17(1). 62–62. 12 indexed citations

Zhou, Feng, Shuai Gao, Dong Han, et al.. (2019). TMPRSS2-ERG activates NO-cGMP signaling in prostate cancer cells. Oncogene. 38(22). 4397–4411. 33 indexed citations

10.

Zhou, Feng, et al.. (2019). miRNA-221 promotes cutaneous squamous cell carcinoma progression by targeting PTEN. Cellular & Molecular Biology Letters. 24(1). 9–9. 43 indexed citations

11.

Choudhury, Samrat Roy, et al.. (2016). ZnO nanoparticles induced reactive oxygen species promotes multimodal cyto- and epigenetic toxicity. Toxicological Sciences. 156(1). kfw252–kfw252. 67 indexed citations

12.

Xiong, Ying, et al.. (2015). MiR-939 promotes the proliferation of human ovarian cancer cells by repressing APC2 expression. Biomedicine & Pharmacotherapy. 71. 64–69. 53 indexed citations

13.

Shi, Jing, et al.. (2015). Synaptic vesicle protein2A decreases in amygdaloid-kindling pharmcoresistant epileptic rats. Journal of Huazhong University of Science and Technology [Medical Sciences]. 35(5). 716–722. 8 indexed citations

14.

Zhou, Feng. (2013). Reform of University Teaching Methods. Higher education of social science. 4(1). 24–26.

15.

Dong, Qing, Douglas R. Dougan, Xianchang Gong, et al.. (2011). Discovery of TAK-733, a potent and selective MEK allosteric site inhibitor for the treatment of cancer. Bioorganic & Medicinal Chemistry Letters. 21(5). 1315–1319. 93 indexed citations

16.

Wang, Liying, Zengxia Li, Can Wang, et al.. (2008). E-cadherin decreased human breast cancer cells sensitivity to staurosporine by up-regulating Bcl-2 expression. Archives of Biochemistry and Biophysics. 481(1). 116–122. 26 indexed citations

17.

Zhou, Feng, Le Fu, Yong Yang, et al.. (2008). Unglycosylation at Asn-633 made extracellular domain of E-cadherin folded incorrectly and arrested in endoplasmic reticulum, then sequentially degraded by ERAD. Glycoconjugate Journal. 25(8). 727–740. 35 indexed citations

18.

Ponnappa, Biddanda C., et al.. (2004). Inhibition of tumor necrosis factor alpha secretion and prevention of liver injury in ethanol-fed rats by antisense oligonucleotides. Biochemical Pharmacology. 69(4). 569–577. 25 indexed citations

19.

Ponnappa, Biddanda C., et al.. (2001). In Vivo Delivery of Antisense Oligonucleotides in pH-Sensitive Liposomes Inhibits Lipopolysaccharide-Induced Production of Tumor Necrosis Factor-α in Rats. Journal of Pharmacology and Experimental Therapeutics. 297(3). 1129–1136. 14 indexed citations

20.

Hainline, Brian, et al.. (1995). Fetal Tissue Derived From Spontaneous Pregnancy Losses Is Insufficient for Human Transplantation. Obstetrics and Gynecology. 85(4). 619–624. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact